Annual FCF
-$8.82 M
-$16.40 K-0.19%
December 31, 2023
Summary
- As of February 7, 2025, BDRX annual free cash flow is -$8.82 million, with the most recent change of -$16.40 thousand (-0.19%) on December 31, 2023.
- During the last 3 years, BDRX annual FCF has risen by +$3.38 million (+27.73%).
- BDRX annual FCF is now -25.68% below its all-time high of -$7.02 million, reached on December 1, 2013.
Performance
BDRX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
BDRX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.2% | - | - |
| 3 y3 years | +27.7% | - | - |
| 5 y5 years | +51.7% | - | - |
BDRX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1.3% | at low | ||||
| 5 y | 5-year | -1.5% | +27.7% | ||||
| alltime | all time | -25.7% | +56.8% |
Biodexa Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$8.82 M(+0.2%) | - | - |
| Dec 2022 | -$8.80 M(+1.1%) | - | - |
| Dec 2021 | -$8.71 M(-28.7%) | - | - |
| Dec 2020 | -$12.21 M(+40.4%) | - | - |
| Dec 2019 | -$8.69 M(-52.4%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$18.27 M(-2.0%) | - | - |
| Dec 2017 | -$18.64 M(-4.8%) | - | - |
| Dec 2016 | -$19.58 M(-4.0%) | - | - |
| Dec 2015 | -$20.40 M(+90.8%) | - | - |
| Dec 2014 | -$10.69 M(+52.3%) | - | - |
| Dec 2013 | -$7.02 M | - | - |
FAQ
- What is Biodexa Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Biodexa Pharmaceuticals?
- What is Biodexa Pharmaceuticals annual FCF year-on-year change?
What is Biodexa Pharmaceuticals annual free cash flow?
The current annual FCF of BDRX is -$8.82 M
What is the all time high annual FCF for Biodexa Pharmaceuticals?
Biodexa Pharmaceuticals all-time high annual free cash flow is -$7.02 M
What is Biodexa Pharmaceuticals annual FCF year-on-year change?
Over the past year, BDRX annual free cash flow has changed by -$16.40 K (-0.19%)